Summary by Futu AI
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a sale of 15,000 shares of common stock on June 12, 2024. The transactions were executed in the open market with prices ranging from $142.97 to $150.24 per share, resulting in a total market value of $2,208,071.31. Following the sales, Afeyan directly holds 2,314,015 shares of Moderna. Additionally, indirect holdings through various entities associated with Flagship Pioneering total 4,632,149 shares, with the largest portion, 3,880,328 shares, held by Flagship Ventures Fund IV, L.P.